Successful therapy with bevacizumab combined with corticosteroids for crizotinib-induced interstitial lung disease

We present the case of an old woman with ALK-rearranged stage IV lung adenocarcinoma who received crizotinib. She presented with severe dyspnea on the 34th day, and diffuse ground-glass opacifications in her chest. A diagnosis of crizotinib-induced ILD was confirmed. Corticosteroids were administere...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Angiogenesis
Main Authors: Xie, Xiaohong, Guo, Bingpeng, Lin, Xinqing, Qin, Yinyin, Ouyang, Ming, Li, Shiyue, Zhou, Chengzhi
Format: Artigo
Jezik:Inglês
Izdano: Springer Netherlands 2019
Teme:
Perspective
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6863787/
https://ncbi.nlm.nih.gov/pubmed/31250326
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10456-019-09673-1
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki